Innoviva (INVA) Selling, General & Administrative (2010 - 2026)

Innoviva (INVA) Selling, General & Administrative (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 582.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 662.10 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.13 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 110.21 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 593.21 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 2,715.95
7 Royalty Pharma 33.72 Bn 35.84 Bn - 161.89 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 347.92 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 247.47 Mn
10 Innoviva 1.54 Bn 968.79 Mn 90.62 Mn 34.57 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 34.57 Mn
Mar 31, 2026 32.44 Mn
Sep 30, 2025 81.19 Mn
Jun 30, 2025 26.41 Mn
Mar 31, 2025 27.49 Mn
Sep 30, 2024 84.36 Mn
Jun 30, 2024 27.74 Mn
Mar 31, 2024 30.41 Mn
Sep 30, 2023 71.91 Mn
Jun 30, 2023 23.54 Mn
Mar 31, 2023 19.74 Mn
Sep 30, 2022 46.08 Mn
Jun 30, 2022 11.78 Mn
Mar 31, 2022 6.49 Mn
Sep 30, 2021 13.07 Mn
Jun 30, 2021 4.23 Mn
Mar 31, 2021 5.99 Mn
Dec 31, 2020 5.47 Mn
Sep 30, 2020 3.25 Mn
Jun 30, 2020 2.60 Mn